Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment

BMC Neurology

Volumn 10, Issue , 2010, Pages

  Fernández, Manuel ^a   Gobartt, Ana L ^b   Balañá, Montse ^b  

^a HOSPITAL DE CRUCES   (Spain)

^b Departamento Médico   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DONEPEZIL; MEMANTINE; RISPERIDONE; RIVASTIGMINE;

ADAS NONCOG SCORE; AGED; ALZHEIMER DISEASE; APATHY; APPETITE DISORDER; ARTICLE; BEHAVIOR DISORDER; CLINICAL FEATURE; COGNITIVE DEFECT; CONCENTRATION LOSS; CONTROLLED STUDY; COOPERATION; DELIRIUM; DELUSION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTIONAL DISORDER; FEMALE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI MENTAL STATE EXAMINATION; SCORING SYSTEM; SYMPTOM; TREMOR; BEHAVIOR; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PREVALENCE; PSYCHOLOGICAL ASPECT;

AGED; ALZHEIMER DISEASE; BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PREVALENCE;

EID: 77957130057     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-10-87     Document Type: Article

References (62)

1. Brookmeyer R, Gray S. Methods for projecting the incidence and prevalence of chronic diseases in aging populations: application to Alzheimer's disease. Stat Med 2000, 19(11-12):1481-1493. 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1481::AID-SIM440>3.0.CO;2-U, 10844713.
2. Rubin EH, Kinscherf DA. Psychopathology of very mild dementia of the Alzheimer type. Am J Psychiatry 1989, 146(8):1017-1021.
3. Petry S, Cummings JL, Hill MA, Shapira J. Personality alterations in dementia of the Alzheimer type. Arch Neurol 1988, 45(11):1187-1190.
4. Artaso Irigoyen B, Goni Sarries A, Gomez Martinez AR. Neuropsychiatric symptoms in dementia syndrome. Rev Neurol 2004, 38(6):506-510.
5. Swearer JM, Drachman DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviours in dementia. Relationships to diagnosis and disease severity. J Am Geriatr Soc 1988, 36(9):784-790.
6. Lyketsos CG, Steele C, Baker L, Galik E, Kopunek S, Steinberg M, Warren A. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci 1997, 9(4):556-561.
7. Mok WY, Chu LW, Chung CP, Chan NY, Hui SL. The relationship between non-cognitive symptoms and functional impairment in Alzheimer's disease. Int J Geriatr Psychiatry 2004, 19(11):1040-1046. 10.1002/gps.1207, 15481076.
8. Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, et al. Predicting time to nursing home care and death in individuals with Alzheimer disease. Jama 1997, 277(10):806-812. 10.1001/jama.277.10.806, 9052710.
9. Gonzalez-Salvador T, Lyketsos CG, Baker A, Hovanec L, Roques C, Brandt J, Steele C. Quality of life in dementia patients in long-term care. Int J Geriatr Psychiatry 2000, 15(2):181-189. 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I, 10679850.
10. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry 1990, 147(8):1049-1051.
11. Hebert R, Dubois MF, Wolfson C, Chambers L, Cohen C. Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 2001, 56(11):M693-699.
12. Fillit H, Cummings J. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Manag Care Interface 2000, 13(1):51-56.
13. Lopez-Pousa S, Garre-Olmo J, Vilalta-Franch J, Turon-Estrada A, Pericot-Nierga I. Trazodone for Alzheimer's disease: a naturalistic follow-up study. Archives of gerontology and geriatrics 2008, 47(2):207-215. 10.1016/j.archger.2007.07.010, 17897735.
14. Cummings JL, Mackell J, Kaufer D. Behavioural effects of current Alzheimer's disease treatments: a descriptive review. Alzheimers Dement 2008, 4(1):49-60. 10.1016/j.jalz.2007.10.011, 18631950.
15. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. Jama 2002, 288(12):1475-1483. 10.1001/jama.288.12.1475, 12243634.
16. Ikeda M, Fukuhara R, Shigenobu K, Hokoishi K, Maki N, Nebu A, Komori K, Tanabe H. Dementia associated mental and behavioural disturbances in elderly people in the community: findings from the first Nakayama study. J Neurol Neurosurg Psychiatry 2004, 75(1):146-148. 1757456, 14707327.
17. Lyketsos CG, Sheppard JM, Steinberg M, Tschanz JA, Norton MC, Steffens DC, Breitner JC. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int J Geriatr Psychiatry 2001, 16(11):1043-1053. 10.1002/gps.448, 11746650.
18. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioural changes in Alzheimer's disease. Neurology 1996, 46(1):130-135.
19. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994, 44(12):2308-2314.
20. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioural symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987, 48(Suppl):9-15.
21. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984, 141(11):1356-1364.
22. Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983, 19(3):448-450.
23. Manzano JM, Llorca G, Ledesma A, Lopez-Ibor JJ. Spanish adaptation of the Alzheimer's disease assessment scale (ADAS). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1994, 22(2):64-70.
24. Pena-Casanova J, Aguilar M, Santacruz P, Bertran-Serra I, Hernandez G, Sol JM, Pujol A, Blesa R. Adaptation and normalization of the Alzheimer's disease Assessment Scale for Spain (NORMACODEM) (II). Neurologia 1997, 12(2):69-77.
25. Finkel SI, Costae Silva J, Cohen G, Miller S, Sartorius N. Behavioural and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int Psychogeriatr 1996, 8(Suppl 3):497-500.
26. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry 2005, 162(11):2086-2093. 10.1176/appi.ajp.162.11.2086, 16263848.
27. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry 2003, 160(5):857-866. 10.1176/appi.ajp.160.5.857, 12727688.
28. Marin DB, Green CR, Schmeidler J, Harvey PD, Lawlor BA, Ryan TM, Aryan M, Davis KL, Mohs RC. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. J Am Geriatr Soc 1997, 45(11):1331-1338.
29. Tariot PN, Mack JL, Patterson MB, Edland SD, Weiner MF, Fillenbaum G, Blazina L, Teri L, Rubin E, Mortimer JA, et al. The Behaviour Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioural Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 1995, 152(9):1349-1357.
30. Cohen D, Eisdorfer C, Gorelick P, Paveza G, Luchins DJ, Freels S, Ashford JW, Semla T, Levy P, Hirschman R. Psychopathology associated with Alzheimer's disease and related disorders. J Gerontol 1993, 48(6):M255-260.
31. Estevez-Gonzalez A, Garcia-Sanchez C, Boltes A, Garcia-Nonell C, Rigau-Ratera E, Otermin P, Gironell A, Kulisevsky J. Sustained attention in the preclinical phase of Alzheimer's disease. Rev Neurol 2003, 36(9):829-832.
32. Kim EJ, Lee BH, Seo SW, Moon SY, Jung DS, Park KH, Heilman KM, Na DL. Attentional distractibility by optokinetic stimulation in Alzheimer disease. Neurology 2007, 69(11):1105-1112. 10.1212/01.wnl.0000276956.65528.d4, 17846410.
33. Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord 1998, 13(1):5-10. 10.1002/mds.870130105, 9452318.
34. Louis ED, Ford B, Pullman S, Baron K. How normal is 'normal'? Mild tremor in a multiethnic cohort of normal subjects. Arch Neurol 1998, 55(2):222-227. 10.1001/archneur.55.2.222, 9482364.
35. Louis ED, Wendt KJ, Ford B. Senile tremor. What is the prevalence and severity of tremor in older adults?. Gerontology 1998, 46(1):12-16.
36. Fernandez Martinez M, Castro Flores J, Perez de las Heras S, Mandaluniz Lekumberri A, Gordejuela Menocal M, Zarranz Imirizaldu JJ. Prevalence of neuropsychiatric symptoms in elderly patients with dementia in Mungialde County (Basque Country, Spain). Dement Geriatr Cogn Disord 2008, 25(2):103-108. 10.1159/000112215, 18063866.
37. Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord 2004, 18(1):17-21. 10.1097/00002093-200401000-00004, 15195459.
38. Troisi A, Pasini A, Gori G, Sorbi T, Biagini C, Aulisi A, Baroni A, Ciani N. Assessment of depression in Alzheimer's disease: symptoms, syndrome, and computed tomography findings. Dementia 1993, 4(2):87-93.
39. Mackenzie TB, Robiner WN, Knopman DS. Differences between patient and family assessments of depression in Alzheimer's disease. Am J Psychiatry 1989, 146(9):1174-1178.
40. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, Chodakowska-Zebrowska M, Wasiak B, Peplonska B, Barcikowska M. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry 2007, 22(6):563-567. 10.1002/gps.1716, 17136705.
41. Purandare N, Burns A, Craig S, Faragher B, Scott K. Depressive symptoms in patients with Alzheimer's disease. Int J Geriatr Psychiatry 2001, 16(10):960-964. 10.1002/gps.449, 11607939.
42. Verkaik R, Nuyen J, Schellevis F, Francke A. The relationship between severity of Alzheimer's disease and prevalence of comorbid depressive symptoms and depression: a systematic review. Int J Geriatr Psychiatry 2007, 22(11):1063-1086. 10.1002/gps.1809, 17457960.
43. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour. Br J Psychiatry 1990, 157:86-94. 10.1192/bjp.157.1.86, 2397368.
44. Treiber KA, Lyketsos CG, Corcoran C, Steinberg M, Norton M, Green RC, Rabins P, Stein DM, Welsh-Bohmer KA, Breitner JC, et al. Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. Int Psychogeriatr 2008, 20(3):538-553. 10.1017/S1041610208006704, 2692675, 18289451.
45. Cooper JK, Mungas D, Weiler PG. Relation of cognitive status and abnormal behaviours in Alzheimer's disease. J Am Geriatr Soc 1990, 38(8):867-870.
46. Merriam AE, Aronson MK, Gaston P, Wey SL, Katz I. The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc 1988, 36(1):7-12.
47. Lopez OL, Becker JT, Sweet RA, Klunk W, Kaufer DI, Saxton J, Habeych M, DeKosky ST. Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2003, 15(3):346-353.
48. Wilson RS, Tang Y, Aggarwal NT, Gilley DW, McCann JJ, Bienias JL, Evans DA. Hallucinations, cognitive decline, and death in Alzheimer's disease. Neuroepidemiology 2006, 26(2):68-75. 10.1159/000090251, 16352909.
49. Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, et al. Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol 2005, 62(10):1601-1608. 10.1001/archneur.62.10.1601, 16216946.
50. Rapoport MJ, van Reekum R, Freedman M, Streiner D, Simard M, Clarke D, Cohen T, Conn D. Relationship of psychosis to aggression, apathy and function in dementia. Int J Geriatr Psychiatry 2001, 16(2):123-130. 10.1002/1099-1166(200102)16:2<123::AID-GPS260>3.0.CO;2-1, 11241716.
51. White HK, McConnell ES, Bales CW, Kuchibhatla M. A 6-month observational study of the relationship between weight loss and behavioural symptoms in institutionalized Alzheimer's disease subjects. J Am Med Dir Assoc 2004, 5(2):89-97. 10.1016/S1525-8610(04)70061-4, 14984619.
52. Gillette-Guyonnet S, Nourhashemi F, Andrieu S, de Glisezinski I, Ousset PJ, Riviere D, Albarede JL, Vellas B. Weight loss in Alzheimer disease. Am J Clin Nutr 2000, 71(2):637S-642S.
53. Copeland MP, Daly E, Hines V, Mastromauro C, Zaitchik D, Gunther J, Albert M. Psychiatric symptomatology and prodromal Alzheimer's disease. Alzheimer Dis Assoc Disord 2003, 17(1):1-8. 10.1097/00002093-200301000-00001, 12621314.
54. Salzman C. Treatment of agitation, anxiety, and depression in dementia. Psychopharmacol Bull 1988, 24(1):39-42.
55. Reisberg B, Auer SR, Monteiro IM. Behavioural pathology in Alzheimer's disease (BEHAVE-AD) rating scale. Int Psychogeriatr 1996, 8(Suppl 3):301-308. discussion 351-304.
56. Ferretti L, McCurry SM, Logsdon R, Gibbons L, Teri L. Anxiety and Alzheimer's disease. J Geriatr Psychiatry Neurol 2001, 14(1):52-58. 10.1177/089198870101400111, 11281317.
57. Kumar A, Koss E, Metzler D, Moore A, Friedland RP. Behavioural symptomatology in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 1988, 2(4):363-365. 10.1097/00002093-198802040-00005, 3196470.
58. Miller TP, Tinklenberg JR, Brooks JO, Fenn HH, Yesavage JA. Selected psychiatric symptoms associated with rate of cognitive decline in patients with Alzheimer's disease. J Geriatr Psychiatry Neurol 1993, 6(4):235-238.
59. Haider I, Shah A. A pilot study of behavioural and psychological signs and symptoms of dementia in patients of Indian sub-continent origin admitted to a dementia day hospital in the United Kingdom. Int J Geriatr Psychiatry 2004, 19(12):1195-1204. 10.1002/gps.1245, 15526310.
60. Sicras-Mainar A, Vergara J, Leon-Colombo T, Febrer L, Rejas-Gutierrez J. Retrospective comparative analysis of antidementia medication persistence patterns in Spanish Alzheimer's disease patients treated with donepezil, rivastigmine, galantamine and memantine. Rev Neurol 2006, 43(8):449-453.
61. Aalten P, Verhey FR, Boziki M, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, et al. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord 2007, 24(6):457-463. 10.1159/000110738, 17986816.
62. Green CR, Marin DB, Mohs RC, Schmeidler J, Aryan M, Fine E, Davis KL. The impact of behavioural impairment of functional ability in Alzheimer's disease. Int J Geriatr Psychiatry 1999, 14(4):307-316. 10.1002/(SICI)1099-1166(199904)14:4<307::AID-GPS908>3.0.CO;2-E, 10340193.